Related Experiment Video
Updated: May 13, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
The role of homocysteine in bone remodeling
Thomas P Vacek1, Anuradha Kalani, Michael J Voor
1Department of Physiology and Biophysics, University of Louisville School of Medicine Louisville, Louisville, KY 40202, USA.
Insights
High homocysteine (Hcy) levels impact bone remodeling by affecting osteoblasts and osteoclasts. This study proposes a mitochondrial mechanism involving reactive oxygen species (ROS) and matrix metalloproteinases (MMPs) in Hcy-induced bone changes.
Area of Science:
- Biochemistry
- Bone Biology
- Mitochondrial Medicine
Background:
- Homocysteine (Hcy) significantly influences bone remodeling through mechanisms like altered osteoblast/osteoclast activity and direct matrix interaction.
- Elevated Hcy (hyperhomocysteinemia, HHcy) is linked to decreased bone blood flow and increased matrix metalloproteinases (MMPs), potentially weakening bone structure.
- Mitochondria play a key role in reactive oxygen species (ROS) generation, and mitochondrial abnormalities are observed in HHcy, suggesting a role in Hcy's bone effects.
Purpose of the Study:
- To elucidate the largely unknown mitochondrial mechanism by which Hcy induces alterations in bone properties.
- To investigate the role of ROS and MMPs in Hcy-mediated bone matrix degradation via a mitochondrial pathway.
Main Methods:
- The study proposes a hypothetical mitochondrial pathway for Hcy's effects on bone.
- It discusses the role of ROS generated by mitochondria in activating MMPs.
- It considers bone turnover markers like hydroxyproline and N-terminal collagen 1 telopeptides in the context of HHcy.
Main Results:
- Hcy may induce bone alterations through mitochondrial ROS generation, leading to MMP activation and subsequent bone matrix degradation.
- Contrasting reports exist regarding Hcy's effect on bone density.
- Previous studies indicate altered bone biomechanical properties in HHcy and deficiencies in vitamins B12 and folate.
Conclusions:
- A mitochondrial mechanism involving ROS and MMPs is proposed for Hcy's detrimental effects on bone.
- Folate and vitamin therapy may act through both Hcy-dependent and independent pathways.
- Further research is essential to fully clarify the mechanistic role of Hcy in bone diseases.
Abstract:
Bone remodeling is a very complex process. Homocysteine (Hcy) is known to modulate this process via several known mechanisms such as increase in osteoclast activity, decrease in osteoblast activity and direct action of Hcy on bone matrix. Evidence from previous studies further support a detrimental effect on bone via decrease in bone blood flow and an increase in matrix metalloproteinases (MMPs) that degrade extracellular bone matrix. Hcy binds directly to extracellular matrix and reduces bone strength. There are several bone markers that can be used as parameters to determine how high levels of plasma Hcy (hyperhomocysteinemia, HHcy) affect bone such as: hydroxyproline, N-terminal collagen 1 telopeptides. Mitochondrion serves an important role in generating reactive oxygen species (ROS). Mitochondrial abnormalities have been identified during HHcy. The mechanism of Hcy-induced bone remodeling via the mitochondrial pathway is largely unknown. Therefore, we propose a mitochondrial mechanism by which Hcy can contribute to alter bone properties. This may occur both through generations of ROS that activate MMPs and could be extruded into matrix to degrade bone matrix. However, there are contrasting reports on whether Hcy affects bone density, with some reports in favour and others not. Earlier studies also found an alteration in bone biomechanical properties with deficiencies of vitamin B12, folate and HHcy conditions. Moreover, existing data opens speculation that folate and vitamin therapy act not only via Hcy-dependent pathways but also via Hcy-independent pathways. However, more studies are needed to clarify the mechanistic role of Hcy during bone diseases.
Related Concept Videos
Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling and Repair
